<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2310-0265</journal-id>
<journal-title><![CDATA[Revista CON-CIENCIA]]></journal-title>
<abbrev-journal-title><![CDATA[Rev.Cs.Farm. y Bioq]]></abbrev-journal-title>
<issn>2310-0265</issn>
<publisher>
<publisher-name><![CDATA[Facultad de Ciencias Farmacéuticas y BioquímicasUniversidad Mayor de San Andrés]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2310-02652022000100017</article-id>
<article-id pub-id-type="doi">10.53287/tmph6198gn62f</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Adherencia a la medicación mediante el uso del teléfono en pacientes hipertensos crónicos]]></article-title>
<article-title xml:lang="en"><![CDATA[Use of the telephone to optimize adherence to medication in chronic hypertensive patients]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ortega]]></surname>
<given-names><![CDATA[Cesia Berenice Morales]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[Gladys Lugo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Aguilar-Rabito]]></surname>
<given-names><![CDATA[Ana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[Lourdes Samaniego]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Larroza]]></surname>
<given-names><![CDATA[Gladys Mabel Maidana de]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,aff1  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="Af2">
<institution><![CDATA[,aff2  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="Af3">
<institution><![CDATA[,aff3  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="Af4">
<institution><![CDATA[,aff4  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2022</year>
</pub-date>
<volume>10</volume>
<numero>1</numero>
<fpage>17</fpage>
<lpage>32</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_arttext&amp;pid=S2310-02652022000100017&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_abstract&amp;pid=S2310-02652022000100017&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_pdf&amp;pid=S2310-02652022000100017&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción . La mitad de los pacientes hipertensos abandona la terapia a partir del primer año del diagnóstico. El uso del teléfono para mejorar la adherencia es aceptado por los pacientes, a través del envío de mensajes a sus celulares o de llamadas telefónicas concertadas, para hacerles recordar la toma de medicación o información sobre su enfermedad.  Objetivo . Evaluar la adherencia al tratamiento mediante recordatorio por teléfono en pacientes hipertensos que retiran sus medicamentos de una Clínica de la seguridad social en Paraguay.  Metodología: Estudio cuasi experimental; aplicando una encuesta y seguimiento mediante contacto telefónico para evaluar la adherencia a la terapia.  Resultados:  El 50% (n=11) de los pacientes se clasificaron como no adherentes a la terapia farmacológica; al final de las intervenciones se redujo a 9,1%. La causa principal de la falta de adherencia fue el olvido, 90,9%. La adherencia al tratamiento mejoro significativamente luego de las intervenciones.  Conclusión:  La utilización de la tecnología podría constituirse en una herramienta para la prevención primaria en la población con factores de riesgo, y el seguimiento de pacientes con hipertensión arterial.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction:  Half of hypertensive patients drop out of therapy from the first year of diagnosis. The use of the telephone to improve adherence is accepted by patients, through sending messages to their cell phones or concerted phone calls, to remind them of taking medication or information about their disease.  Objective:  This work evaluated the use of technology to optimize the adherence of hypertensive patients who withdraw their medicines from a social security clinic in Paraguay.  Methodology:  Quasi-experimental study; applying a survey and follow-up through telephone contact to evaluate adherence to therapy.  Results:  50% (n=11) of patients were classified as non-adherent to drug therapy; at the end of the interventions it was reduced to 9.1%. The main cause of the lack of adherence was forgetfulness, 90.9%. Adherence to treatment improved significantly after interventions.  Conclusion:  The use of technology could be a tool for primary prevention in the population with risk factors, and the monitoring of patients with blood pressure.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[hipertensión arterial]]></kwd>
<kwd lng="es"><![CDATA[intervención farmacéutica]]></kwd>
<kwd lng="es"><![CDATA[adherencia]]></kwd>
<kwd lng="es"><![CDATA[tecnología]]></kwd>
<kwd lng="en"><![CDATA[arterial hypertension]]></kwd>
<kwd lng="en"><![CDATA[adherence]]></kwd>
<kwd lng="en"><![CDATA[technology]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aid Kunert]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adherencia al tratamiento antihipertensivo en pacientes ambulatorios de un hospital urbano]]></article-title>
<source><![CDATA[Revista Virtual de la Sociedad Paraguaya de Medicina Interna]]></source>
<year>2015</year>
<volume>2</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>43-51</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Caro]]></surname>
<given-names><![CDATA[J. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Salas]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Speckman]]></surname>
<given-names><![CDATA[J. L.]]></given-names>
</name>
<name>
<surname><![CDATA[Raggio]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Jackson]]></surname>
<given-names><![CDATA[J. D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Persistence with treatment for hypertension in actual practice]]></article-title>
<source><![CDATA[Cmaj]]></source>
<year>1999</year>
<volume>160</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>31-7</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="">
<collab>CIOMS</collab>
<source><![CDATA[Pautas éticas internacionales para la investigación relacionada con la salud con seres humanos. Pautas éticas internacionales para la investigación biomédica en seres humanos]]></source>
<year>2016</year>
<page-range>136</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Díaz Molina C]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Herrera Preval]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Matéu López]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Adherencia al tratamiento antihipertensivo en pacientes del municipio San Miguel del Padrón\ Instituto de Farmacia y Alimentos]]></source>
<year>2014</year>
<publisher-loc><![CDATA[La Habana, Cuba ]]></publisher-loc>
<publisher-name><![CDATA[Universidad de la Habana]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Durán-Varela]]></surname>
<given-names><![CDATA[B. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Rivera-Chavira]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Franco-Gallegos]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Apego al tratamiento farmacológico en pacientes con diagnóstico de diabetes mellitus tipo 2]]></article-title>
<source><![CDATA[Salud pública de México]]></source>
<year>2001</year>
<volume>43</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>233-6</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Frías]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[El manejo del paciente hipertenso con dislipidemia]]></source>
<year>2019</year>
<page-range>1-3</page-range><publisher-name><![CDATA[SEA]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García-Falcón]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Lores-Delgado]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Dupotey-Varela]]></surname>
<given-names><![CDATA[N. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Espino-Leyva]]></surname>
<given-names><![CDATA[D. L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Atención Farmacéutica en adultos mayores hipertensos. Una experiencia en la atención primaria de salud en Cuba]]></article-title>
<source><![CDATA[Ars Pharmaceutica]]></source>
<year>2018</year>
<volume>59</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>91-8</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[González Alfonso]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Vázquez González]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[González Alfonso]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez Pacheco]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Importancia de la participación familiar en el control de la hipertensión arterial]]></article-title>
<source><![CDATA[Medicentro]]></source>
<year>2004</year>
<volume>8</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>1-7</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="">
<collab>KDIGO</collab>
<source><![CDATA[KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Leon]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Surender]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Bobrow]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Muller]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Farmer]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Improving treatment adherence for blood pressure lowering via mobile phone SMS-messages in South Africa: a qualitative evaluation of the SMS-text Adherence SuppoRt (StAR) trial]]></article-title>
<source><![CDATA[BMC family practice]]></source>
<year>2015</year>
<volume>16</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-10</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lugo]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Bittner]]></surname>
<given-names><![CDATA[M. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Chávez]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Implementación de un Programa de Atención Farmacéutica en Farmacias Comunitarias para la detección de la Hipertensión Arterial y su Seguimiento Farmacoterapéutico]]></article-title>
<source><![CDATA[Lat Am J Pharm]]></source>
<year>2007</year>
<volume>26</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>590-5</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maidana]]></surname>
<given-names><![CDATA[G. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Lugo]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Vera]]></surname>
<given-names><![CDATA[Z.]]></given-names>
</name>
<name>
<surname><![CDATA[Acosta]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Morinigo]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Isasi]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Mastroianni]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores que determinan la falta de adherencia de pacientes diabéticos a la terapia medicamentosa]]></article-title>
<source><![CDATA[Memorias del instituto de investigaciones en ciencias de la salud]]></source>
<year>2016</year>
<volume>14</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maidana]]></surname>
<given-names><![CDATA[G. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Lugo]]></surname>
<given-names><![CDATA[G. B.]]></given-names>
</name>
<name>
<surname><![CDATA[Vera]]></surname>
<given-names><![CDATA[Z.]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Mastroianni]]></surname>
<given-names><![CDATA[P. C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluación de un programa de Atención Farmacéutica en pacientes con Diabetes Mellitus Tipo 2]]></article-title>
<source><![CDATA[Pharmaceutical Care España]]></source>
<year>2016</year>
<volume>18</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>3-15</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mapes]]></surname>
<given-names><![CDATA[R. E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Physician's drug innovation and relinquishment]]></article-title>
<source><![CDATA[Social Science &amp; Medicine]]></source>
<year>1977</year>
<volume>11</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>619-24</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Efectos de la intervención farmacéutica en pacientes con presión arterial elevada sin tratamiento]]></source>
<year>2008</year>
<edition>Segunda</edition>
<page-range>1-294</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morisky]]></surname>
<given-names><![CDATA[D. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Ang]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Krousel&#8208;Wood]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Ward]]></surname>
<given-names><![CDATA[H. J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Predictive validity of a medication adherence measure in an outpatient setting]]></article-title>
<source><![CDATA[The journal of clinical hypertension]]></source>
<year>2008</year>
<volume>10</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>348-54</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ortellado]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Ramírez]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Filizzola]]></surname>
<given-names><![CDATA[G. O.]]></given-names>
</name>
<name>
<surname><![CDATA[de Doll]]></surname>
<given-names><![CDATA[M. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Sano]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Caballero]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Consenso paraguayo de hipertensión arterial 2015]]></article-title>
<source><![CDATA[Revista Virtual de la Sociedad Paraguaya de Medicina Interna]]></source>
<year>2016</year>
<numero>11</numero>
<issue>11</issue>
<page-range>57</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pagès-Puigdemont]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Valverde-Merino]]></surname>
<given-names><![CDATA[M. I.]]></given-names>
</name>
<name>
<surname><![CDATA[Faus Dáder]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adherencia terapéutica: factores modificadores y estrategias de mejora]]></article-title>
<source><![CDATA[ArsPharm]]></source>
<year></year>
<volume>59</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>251-8</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ramírez Pinzón]]></surname>
<given-names><![CDATA[C. J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adherencia a la farmacoterapia en pacientes hipertensos ambulatorios que asisten al programa de control de hipertensión arterial en el Hospital Jorge Cristo Sahium, Norte de Santander (Colombia)]]></article-title>
<source><![CDATA[Ciencia y Tecnología para la Salud Visual y Ocular]]></source>
<year>2014</year>
<volume>12</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>27-35</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[Germán Enrique]]></given-names>
</name>
<name>
<surname><![CDATA[Galeano]]></surname>
<given-names><![CDATA[Esmeralda]]></given-names>
</name>
<name>
<surname><![CDATA[Correa]]></surname>
<given-names><![CDATA[Jaime Orlando]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adherencia al tratamiento Implicaciones de la no-adherencia.]]></article-title>
<source><![CDATA[Acta Médica Colombiana]]></source>
<year>2005</year>
<volume>30</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>268-73</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vivian]]></surname>
<given-names><![CDATA[E. M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Improving blood pressure control in a pharmacist&#8208;managed hypertension clinic]]></article-title>
<source><![CDATA[Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy]]></source>
<year>2002</year>
<volume>22</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1533-40</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
